Physician

Margaret R. Zelasko, M.D.

According to 2025 Medicare claims, Margaret Zelasko, M.D. (NPI: 1225355613) practices internal medicine in the Muncie, IN market, with the plurality of this provider's patient population coming from Delaware, IN. This provider's primary affiliated billing organization is ROYALE INTERNAL MEDICINE, LLC (NPI: 1225450836; TIN: 46-3986500) and primary practice location at 47304-2264. Zelasko is affiliated with the Emory Healthcare Network Advantage (ACO ID: A4771) and Aledade 103 Upper Midwest MSSP (ACO ID: A5003), participating under the MSSP model.

Zelasko's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,177 traditional Medicare patients, billed 20,615 HCPCS/CPT codes, and received $571,068 in Medicare payments. The top billing code was 91320 (Sarscv2 vac 30mcg trs-suc im). Part D data shows 13,634 prescription claims across 1,003 beneficiaries totaling $1,945,496 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 284 claims. Open Payments data shows 157 records totaling $2,619. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $719,307 to $1,945,496. In contrast, DME billing represents a smaller volume and rose steadily, from $12,091 to $18,184.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	977	34,958	$449,557
2016	868	39,180	$434,778
2017	739	35,129	$388,575
2018	638	32,811	$421,056
2019	656	32,637	$415,698
2020	717	32,908	$391,507
2021	900	29,238	$458,717
2022	806	25,425	$522,328
2023	1,046	21,086	$532,649
2024	1,177	20,615	$571,068

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	490	7,876	$719,307
2016	537	9,128	$828,064
2017	514	9,257	$783,562
2018	539	9,728	$833,138
2019	583	10,022	$873,703
2020	726	11,058	$1,040,972
2021	855	11,592	$1,230,747
2022	870	11,764	$1,394,531
2023	978	12,749	$1,671,738
2024	1,003	13,634	$1,945,496

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	44	129	$8,303
2016	120	355	$12,456
2017	150	385	$10,212
2018	146	373	$9,737
2019	145	373	$11,440
2020	105	350	$14,216
2021	134	389	$16,210
2022	115	399	$17,836
2023	87	305	$28,438
2024	87	284	$16,592

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
91320	Sarscv2 vac 30mcg trs-suc im	649	650	$153
90653	Influenza vaccine, inactivated	914	914	$82
90480	Admn sarscov2 vacc 1 dose	649	650	$40
G0008	Administration of influenza virus vaccine	941	941	$30
36415	Insertion of needle into vein for collection of blood sample	368	1,111	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	182	8,046	$286,281
Eliquis	Apixaban	153	9,866	$184,052
Jardiance	Empagliflozin	103	7,044	$131,882
Ozempic	Semaglutide	96	4,016	$126,542
Soliqua 100-33	Insulin Glargine/Lixisenatide	90	4,714	$109,354

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	15	$6,634
A7031	Face mask interface, replacement for full face mask, each	N	11	23	$2,099
A7030	Full face mask used with positive airway pressure device, each	N	N/R	20	$1,662
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	25	$1,610
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	N/R	18	$1,111

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	157	$2,619	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Margaret R. Zelasko, M.D.?

Tedicare shows public-source Medicare data for Margaret R. Zelasko, M.D. (NPI 1225355613), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Margaret R. Zelasko, M.D. have ACO affiliation data?

Margaret R. Zelasko, M.D. is shown with ACO affiliation data for Emory Healthcare Network Advantage (MSSP, ACO ID A4771) and Aledade 103 Upper Midwest MSSP (MSSP, ACO ID A5003).

What billing organization is linked to Margaret R. Zelasko, M.D.?

Margaret R. Zelasko, M.D. is linked to ROYALE INTERNAL MEDICINE, LLC (billing NPI 1225450836) in the available physician profile data.

Does Margaret R. Zelasko, M.D. have Open Payments data?

Margaret R. Zelasko, M.D. has 157 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.